Clinical Trial Update: A Single-dose Trial to Investigate the Safety and Tolerability of XEN-D0501 in Patients With Diabetes Mellitus Type 2 [Phase 2]

View source ↗

Summary

Phase 2 single-dose study assessing safety and tolerability of XEN-D0501 in adults with Type 2 diabetes; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• XEN-D0501

Snippet

Sponsor: Pila Pharma | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED